Loading…
Loading…
UK's $20B defense overhaul puts defense ETFs in focus as higher military spending could boost key holdings across the industry.
BAE Systems PLC (LSE:BA.), Chemring Group (LSE:CHG) and other UK defence stocks rallied after the government confirmed a £15 billion increase in military spending, with drones, ammunition stockpiles and the nuclear deterrent among the priorities.
Chemring Group (LSE:CHG) has secured up to $345 million of new US defence awards that will allow it to restart manufacturing at its previously discontinued Alloy Surfaces business in Philadelphia. The defence technology group said the US Department of War had awarded a modified five-year 'indefinite delivery, indefinite quantity' contract worth up to $300 million to produce pyrophoric airborne decoys.
Chemring Group PLC (CMGMY) Q2 2026 Earnings Call Transcript
Chemring Group LON: CHG said first-half trading was in line with expectations and reiterated its full-year outlook, supported by a record order book and stronger order visibility across its defense and national security businesses.
Chemring Group (LSE:CHG) reported lower first-half profits but a record order book, and said it remained on track to meet full-year expectations as rising global defence spending continued to support demand across its core markets. The maker of chaff, energetics, sensors and other defence technology posted revenue of £237.3 million for the six months to 30 April, up 7% from £222.8 million a year earlier.
UK defence stocks could regain momentum once the long-delayed Defence Investment Plan is finally published, according to Jefferies, which said the sector still offers some of the strongest long-term growth prospects in the London market. The US bank's defence and aerospace team said the absence of the government's defence spending roadmap had weighed on sentiment for more than six months, alongside political uncertainty and higher borrowing costs.
Chemring Group (LSE:CHG) shares fell 5% to 495p after the defence technology group flagged a slower-than-expected start to its financial year, driven by manufacturing problems at a US facility, and warned that rising capital expenditure would push debt higher. The group's Kilgore Flares plant in Tennessee, which operates a fully automated countermeasures production line, experienced operational difficulties that are now largely resolved.
No recent filings indexed.